Statistics for Tarsus Pharmaceuticals (id:8060 TARS)

Valuation metrics

Market cap

1.78B

Enterprise value

1.54B

Trailing P/E (ttm)

-10.44

Forward P/E

-21.60

PEG ratio

-21.60

Price/Sales (ttm)

13.76

Price/Book (mrq)

7.50

Enterprise Value/Revenue

11.87

Enterprise Value/EBITDA

-11.03

Overview

Shares outstanding

38.04M

Float

28.97M

Shares short

8.16M

% Held by insiders

0.09%

% Held by institutions

1.19%

Average volume (10 days)

998.32K

Average volume (90 days)

Price summary

52-Week low

15.60

52-Week high

52.99

52-Week change

65.05%

Beta

1.00

50-Day moving average

37.17

200-Day moving average

32.64

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-103.64%

Operating margin

-52.29%

Operational effectiveness

Return on assets

-27.26%

Return on equity

-59.56%

Income statement

Revenue (ttm)

3.57

Revenue per share (ttm)

3.57

Quarterly revenue growth (yoy)

Gross profit (ttm)

15.85M

EBITDA

-139,458,000.00

Net income to common (ttm)

-134,343,008.00

Diluted EPS (ttm)

-4.47

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

316.95M

Total cash per share (mrq)

8.29

Total debt (mrq)

71.71M

Total Debt/Equity (mrq)

30.20

Current ratio (mrq)

542.20%

Book value per share (mrq)

6.22

Cash flow

Cash flow statement

-100,180,000.00

Levered free cash flow (LFCF)

-71,101,504.00